Andina Acquisition Corporation III (Andina III) is a blank check company formed in January 2019 for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more target businesses. We are a publicly listed company on the Nasdaq stock exchange under the ticker ANDA. Our management team has a successful track record having closed two prior business combinations under Andina I and Andina II.

On July 22, 2020 Andina III and EMMAC Life Sciences Limited jointly announced the signing of a non-binding letter of intent relating to a business combination. Through this transaction EMMAC would become a publicly traded company on the NASDAQ Stock Market. EMMAC is Europe’s largest independent cannabis company, bringing together cutting-edge scientific research with the latest innovations in medical cannabis cultivation, extraction and production.